Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AD-209 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing efficacy and safety of AD-209 for hypertension (essential hypertension) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension
• Hypertension

Drugs mentioned

• AD-209

Snippet

Sponsor: Addpharma Inc. | Conditions: Hypertension, Essential | Phase 2 | Status: COMPLETED